Exome-based case–control association study using extreme phenotype design reveals novel candidates with protective effect in diabetic retinopathy

Human Genetics

Volumn 135, Issue 2, 2016, Pages 193-200

  Shtir, Corina ^a   Aldahmesh, Mohammed A ^b   Al Dahmash, Saad ^c   Abboud, Emad ^d   Alkuraya, Hisham ^e   Abouammoh, Marwan A ^c   Nowailaty, Sawsan R ^h   Al Thubaiti, Ghazai ^h   Naim, E A ^b,f   ALYounes, B ^b,f   Binhumaid, F S ^b,f   ALOtaibi, A B ^f,g   Altamimi, A S ^f,g   Alamer, F H ^f,g   Hashem, Mais ^b   Abouelhoda, Mohamed ^f   Monies, Dorota ^b,f   Alkuraya, Fowzan S ^b,f  

^a Thermo Fisher Scientific   (United States)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d HEART AND VASCULAR INSTITUTE   (United Arab Emirates)

^e Specialized Medical Center Hospital ^*  (Saudi Arabia)

^f Saudi Human Genome Project   (Saudi Arabia)

^g KING ABDULAZIZ CITY FOR SCIENCE AND TECHNOLOGY   (Saudi Arabia)

^h KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; EXOME; FASTK GENE; FISHER EXACT TEST; GENE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; LOC728699 GENE; NME3 GENE; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; ALLELE; DNA SEQUENCE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MULTIVARIATE ANALYSIS; SAUDI ARABIA; SINGLE NUCLEOTIDE POLYMORPHISM;

FASTK PROTEIN, HUMAN; GENETIC MARKER; NME3 PROTEIN, HUMAN; NUCLEOSIDE DIPHOSPHATE KINASE NM23; PROTEIN SERINE THREONINE KINASE;

ALLELES; CASE-CONTROL STUDIES; DIABETIC RETINOPATHY; EXOME; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MULTIVARIATE ANALYSIS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; SAUDI ARABIA; SEQUENCE ANALYSIS, DNA;

EID: 84954386909     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-015-1624-8     Document Type: Article

References (27)

1. Abhary S, Hewitt AW, Burdon KP, Craig JE (2009) A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes 58:2137–2147
2. Arar NH, Freedman BI, Adler SG, Iyengar SK, Chew EY, Davis MD, Satko SG, Bowden DW, Duggirala R, Elston RC (2008) Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci 49:3839–3845
3. Barnett IJ, Lee S, Lin X (2013) Detecting rare variant effects using extreme phenotype sampling in sequencing association studies. Genet Epidemiol 37:142–151
4. Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376:124–136. doi:10.1016/S0140-6736(09)62124-3
5. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH (2004) Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305:869–872
6. Emond MJ, Louie T, Emerson J, Zhao W, Mathias RA, Knowles MR, Wright FA, Rieder MJ, Tabor HK, Nickerson DA (2012) Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Nat Genet 44:886–889
7. Group EDPR (2004) The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 122:552
8. Hietala K, Forsblom C, Summanen P, Groop P-H (2008) Heritability of proliferative diabetic retinopathy. Diabetes 57:2176–2180
9. Hosseini SM, Boright AP, Sun L, Canty AJ, Bull SB, Klein BE, Klein R, Paterson AD, Group DER (2015) The association of previously reported polymorphisms for microvascular complications in a meta-analysis of diabetic retinopathy. Hum Genet 134:247–257
10. Kuo JZ, Wong TY, Rotter JI (2014) Challenges in elucidating the genetics of diabetic retinopathy. JAMA ophthalmology 132:96–107
11. Li B, Leal SM (2008) Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet 83:311–321
12. Li D, Lewinger JP, Gauderman WJ, Murcray CE, Conti D (2011) Using extreme phenotype sampling to identify the rare causal variants of quantitative traits in association studies. Genet Epidemiol 35:790–799
13. Li B, Liu DJ, Leal SM (2013) Identifying rare variants associated with complex traits via sequencing. Curr Protoc Hum Genet 1.26. 1–1.26. 22. doi:10.1002/0471142905.hg0126s78
14. Löbbert RW, Winterpacht A, Seipel B, Zabel BU (1996) Molecular cloning and chromosomal assignment of the human homologue of the rat cGMP-inhibited phosphodiesterase 1 (PDE3A)—A gene involved in fat metabolism located at 11p15. 1. Genomics 37:211–218
15. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A (2009) Finding the missing heritability of complex diseases. Nature 461:747–753
16. McAuley AK, Wang JJ, Dirani M, Connell PP, Lamoureux E, Hewitt AW (2014) Replication of genetic loci implicated in diabetic retinopathy. Invest Ophthalmol Vis Sci 55:1666–1671
17. McCarthy JJ, McLeod HL, Ginsburg GS (2013) Genomic medicine: a decade of successes, challenges, and opportunities. Sci Transl Med 5:189sr4–189sr4
18. Mohamed Q, Gillies MC, Wong TY (2007) Management of diabetic retinopathy: a systematic review. JAMA 298:902–916
19. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S (2013) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 380:2197–2223
20. Petrovič D (2013) Candidate genes for proliferative diabetic retinopathy. Biomed Res Int 2013. doi:10.1155/2013/540416
21. Rose R, Liu H, Palmer D, Maurice D (1997) Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity. Br J Pharmacol 122:233–240
22. Roy MS, Klein R, O’Colmain BJ, Klein BE, Moss SE, Kempen JH (2004) The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch Ophthalmol 122:546–551. doi:10.1001/archopht.122.4.546
23. Shamoon H, Duffy H, Fleischer N, Engel S, Saenger P, Strelzyn M, Litwak M, Wylierosett J, Farkash A, Geiger D (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes-mellitus. N Engl J Med 329:977–986
24. Shi G, Rao D (2011) Optimum designs for next-generation sequencing to discover rare variants for common complex disease. Genet Epidemiol 35:572–579
25. Tian Q, Taupin J, Elledge S, Robertson M, Anderson P (1995) Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J Exp Med 182:865–874
26. Visscher PM, Brown MA, McCarthy MI, Yang J (2012) Five years of GWAS discovery. Am J Hum Genet 90:7–24
27. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053